272 related articles for article (PubMed ID: 28482407)
1. [Value of texture analysis in evaluating liver cancer recurrence after transarterial chemoembolization].
Wang R; Yang XY; Wang KY; Wang S; Li Q; Wu JF; Xu HT; Dai Y; Han CP; Xu K; Chen GH
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):200-204. PubMed ID: 28482407
[No Abstract] [Full Text] [Related]
2. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
3. Value of texture analysis based on enhanced MRI for predicting an early therapeutic response to transcatheter arterial chemoembolisation combined with high-intensity focused ultrasound treatment in hepatocellular carcinoma.
Yu JY; Zhang HP; Tang ZY; Zhou J; He XJ; Liu YY; Liu XJ; Guo DJ
Clin Radiol; 2018 Aug; 73(8):758.e9-758.e18. PubMed ID: 29804627
[TBL] [Abstract][Full Text] [Related]
4. Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography.
Iwazawa J; Ohue S; Mitani T; Abe H; Hashimoto N; Hamuro M; Nakamura K
AJR Am J Roentgenol; 2009 Apr; 192(4):1057-63. PubMed ID: 19304714
[TBL] [Abstract][Full Text] [Related]
5. C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma.
Iwazawa J; Ohue S; Kitayama T; Sassa S; Mitani T
AJR Am J Roentgenol; 2011 Aug; 197(2):W337-42. PubMed ID: 21785062
[TBL] [Abstract][Full Text] [Related]
6. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
7. Contrast-Enhanced Ultrasonography Versus Contrast-Enhanced Computed Tomography for Assessment of Residual Tumor From Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: A Meta-analysis.
Zhong J; Su Z; Zhang Y; Zhang H; Lin P; Tang X; Zheng R
J Ultrasound Med; 2018 Aug; 37(8):1881-1890. PubMed ID: 29380404
[TBL] [Abstract][Full Text] [Related]
8. Texture Analysis Based on Preoperative Magnetic Resonance Imaging (MRI) and Conventional MRI Features for Predicting the Early Recurrence of Single Hepatocellular Carcinoma after Hepatectomy.
Zhang J; Liu X; Zhang H; He X; Liu Y; Zhou J; Guo D
Acad Radiol; 2019 Sep; 26(9):1164-1173. PubMed ID: 30425000
[TBL] [Abstract][Full Text] [Related]
9. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
10. Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads.
Maschke SK; Werncke T; Klöckner R; Rodt T; Renne J; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Hinrichs JB
Abdom Radiol (NY); 2018 May; 43(5):1245-1253. PubMed ID: 28840307
[TBL] [Abstract][Full Text] [Related]
11. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
[TBL] [Abstract][Full Text] [Related]
12. Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
Liu QY; He CD; Zhou Y; Huang D; Lin H; Wang Z; Wang D; Wang JQ; Liao LP
World J Gastroenterol; 2016 Mar; 22(11):3242-51. PubMed ID: 27004002
[TBL] [Abstract][Full Text] [Related]
13. Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.
Wimmer T; Steiner J; Talakic E; Stauber R; Quehenberger F; Portugaller RH; Schoellnast H
J Comput Assist Tomogr; 2017; 41(5):708-712. PubMed ID: 28296685
[TBL] [Abstract][Full Text] [Related]
14. Quantitative dual-energy CT for evaluating hepatocellular carcinoma after transarterial chemoembolization.
Yue X; Jiang Q; Hu X; Cen C; Song S; Qian K; Lu Y; Yang M; Li Q; Han P
Sci Rep; 2021 May; 11(1):11127. PubMed ID: 34045528
[TBL] [Abstract][Full Text] [Related]
15. The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma.
Du F; Jiang R; Gu M; He C; Guan J
Radiol Med; 2015 Aug; 120(8):690-4. PubMed ID: 25698303
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
Nakano MM; Yamamoto A; Nishida N; Hamuro M; Hamamoto S; Jogo A; Sohgawa E; Kageyama K; Minami T; Miki Y
Jpn J Radiol; 2019 Jul; 37(7):543-548. PubMed ID: 31055710
[TBL] [Abstract][Full Text] [Related]
17. Parametric response mapping cut-off values that predict survival of hepatocellular carcinoma patients after TACE.
Nörthen A; Asendorf T; Shin HO; Hinrichs JB; Werncke T; Vogel A; Kirstein MM; Wacker FK; Rodt T
Abdom Radiol (NY); 2018 Dec; 43(12):3288-3300. PubMed ID: 29680967
[TBL] [Abstract][Full Text] [Related]
18. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
[TBL] [Abstract][Full Text] [Related]
20. Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE).
Mao X; Guo Y; Wen F; Liang H; Sun W; Lu Z
Cancer Imaging; 2021 Aug; 21(1):49. PubMed ID: 34384496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
